CGON CG Oncology, Inc. Common stock
Healthcare$64.25-0.53%ClosedMarket Cap: $5.67B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$82.57
Target (Median)
$82.00
Target Range
$70.00 - $93.00
Upside from current price: 28.5%
Rating Distribution
4 Strong Buy11 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-18 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-05-14 | Truist Securities | maintain | Buy | Buy |
| 2026-05-11 | RBC Capital | maintain | Outperform | Outperform |
| 2026-05-11 | JP Morgan | maintain | Overweight | Overweight |
| 2026-05-11 | Wedbush | maintain | Outperform | Outperform |
| 2026-04-07 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-02-27 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-02-10 | Truist Securities | maintain | Buy | Buy |
| 2026-01-21 | RBC Capital | maintain | Outperform | Outperform |
| 2026-01-16 | Piper Sandler | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-2.84 | $87.2M | 11 |
| Sun Dec 31 | $-0.13 | $457.8M | 11 |
| Mon Dec 31 | $3.28 | $960.8M | 4 |
| Tue Dec 31 | $6.67 | $1.51B | 4 |